首页> 外文期刊>BMC Cancer >Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
【24h】

Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker

机译:干细胞/上皮 - 间充质过渡标志物在血浆/胰腺癌中的预后意义:FGFR1是一个有前途的预后标志物

获取原文
           

摘要

Periampullary cancers (PAC) including pancreatic, ampulla of Vater (AOV), and common bile duct (CBD) cancers are highly aggressive with a lack of useful prognostic markers beyond T stage. However, T staging can be biased due to the anatomic complexity of this region. Recently, several markers related to cancer stem cells and epithelial-mesenchymal transition (EMT) such as octamer transcription factor-4 (Oct4) and fibroblast growth factor receptor 1 (FGFR1) respectively, have been proposed as new promising markers in other solid cancers. The aim of this study was to assess the expression and prognostic significance of stem cell/EMT markers in PACs. Formalin-fixed, paraffin-embedded tissues of surgically excised PACs from the laboratory archives from 1998 to 2014 were evaluated by immunohistochemical staining for stem cell/EMT markers using tissue microarray. The clinicopathologic parameters were documented and statistically analyzed with the immunohistochemical findings. Survival and recurrence data were collected and analyzed. A total of 126 PAC cases were evaluated. The average age was 63?years, with 76 male and 50 female patient samples. Age less than 74?years, AOV cancers, lower T & N stage, lower tumor size, no lymphatic, vascular, perineural invasion and histologic well differentiation, intestinal type, no fibrosis, severe inflammation were significantly associated with the better overall survival High expression levels of FGFR1 as well as CK20, CDX2, and VEGF were significantly related to better overall survival, while other stem cell markers were not related. Similar findings were observed for tumor recurrence using disease-free survival. In addition to other clinicopathologic parameters, severe fibrosis was related to frequent tumor recurrence, and high FGFR1 expression was associated with better overall survival. Histologic changes such as extensive fibrosis need to be investigated further in relation to EMT of PACs.
机译:包括胰腺(AOV)的胰腺癌(PAC)和常见的胆管(CBD)癌症(CBD)癌症(CBD)癌症(AOD)和常见的预后标志物在T阶段缺乏有用的预后标志物。然而,由于该区域的解剖学复杂性,T分期可以偏置。最近,已经提出了与癌症干细胞和上皮 - 间充质转变(EMT)和成纤维细胞生长因子受体1(FGFR1)相关的几个标记,以其他固体癌症中的新有前景标记。本研究的目的是评估干细胞/ EMT标志物在PACS中的表达和预后意义。通过使用组织微阵列的干细胞/ EMT标记的免疫组织化学染色评估来自1998至2014年的实验室档案的手术切除的PACs的石蜡嵌入式组织。记录临床病理学参数并用免疫组织化学发现进行统计分析。收集并分析存活数据和复发数据。共评估126例PAC病例。平均年龄为63岁,年龄为76岁,有76名男性和50名女性患者样品。年龄少于74岁?年龄,AOV癌,降低T&N阶段,肿瘤大小,无淋巴,血管,麻痹侵袭和组织学孔隙分化,肠型,无纤维化,严重炎症与较好的整体存活高表达有显着相关FGFR1和CK20,CDX2和VEGF的水平与更好的整体存活率显着相关,而其他干细胞标记物无关。观察到使用无疾病存活的肿瘤复发的类似发现。除了其他临床病理学参数外,严重的纤维化与频繁的肿瘤复发有关,高FGFR1表达与更好的整体存活相关。需要进一步研究与PACS的EMT进一步调查大规模纤维化的组织学变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号